STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics

被引:60
作者
Kerns, Sarah L. [1 ,2 ,3 ]
de Ruysscher, Dirk [4 ]
Andreassen, Christian N. [5 ]
Azria, David [6 ]
Barnett, Gillian C. [7 ]
Chang-Claude, Jenny [8 ]
Davidson, Susan [9 ]
Deasy, Joseph O. [10 ]
Dunning, Alison M. [11 ]
Ostrer, Harry [2 ,3 ]
Rosenstein, Barry S. [1 ]
West, Catharine M. L. [12 ]
Bentzen, Soren M. [13 ]
机构
[1] Mt Sinai Sch Med, Dept Radiat Oncol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Pathol, New York, NY USA
[3] Albert Einstein Coll Med, Dept Genet, New York, NY USA
[4] Univ Hosp Leuven KU Leuven, Dept Radiat Oncol, Louvain, Belgium
[5] Aarhus Univ Hosp, Dept Expt Clin Oncol, Aarhus, Denmark
[6] Univ Montpellier, Montpellier Canc Inst, Montpellier, France
[7] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England
[8] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany
[9] Christie NHS Fdn Trust Hosp, Dept Clin Oncol, Manchester, Lancs, England
[10] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[11] Univ Cambridge, Strangeways Res Labs, Cambridge CB2 1TN, England
[12] Univ Manchester, Inst Canc Sci, Manchester M13 9PL, Lancs, England
[13] Univ Wisconsin, Dept Human Oncol, Madison, WI 53706 USA
关键词
Radiogenomics; Reporting guidelines; Normal tissue toxicity; Genetics; SINGLE-NUCLEOTIDE POLYMORPHISMS; EARLY BREAST-CANCER; RADIATION-THERAPY; RADIOTHERAPY HYPOFRACTIONATION; UK STANDARDIZATION; CLINICAL-TRIALS; PREDICTION; TOXICITY; METAANALYSIS; ONCOLOGY;
D O I
10.1016/j.radonc.2013.07.011
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite publication of numerous radiogenomics studies to date, positive single nucleotide polymorphism (SNP) associations have rarely been reproduced in independent validation studies. A major reason for these inconsistencies is a high number of false positive findings because no adjustments were made for multiple comparisons. It is also possible that some validation studies were false negatives due to methodological shortcomings or a failure to reproduce relevant details of the original study. Transparent reporting is needed to ensure these flaws do not hamper progress in radiogenomics. In response to the need for improving the quality of research in the area, the Radiogenomics Consortium produced an 18-item checklist for reporting radiogenomics studies. It is recognised that not all studies will have recorded all of the information included in the checklist. However, authors should report on all checklist items and acknowledge any missing information. Use of STROGAR guidelines will advance the field of radiogenomics by increasing the transparency and completeness of reporting. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 42 条
[1]   Prediction of Erectile Function Following Treatment for Prostate Cancer [J].
Alemozaffar, Mehrdad ;
Regan, Meredith M. ;
Cooperberg, Matthew R. ;
Wei, John T. ;
Michalski, Jeff M. ;
Sandler, Howard M. ;
Hembroff, Larry ;
Sadetsky, Natalia ;
Saigal, Christopher S. ;
Litwin, Mark S. ;
Klein, Eric ;
Kibel, Adam S. ;
Hamstra, Daniel A. ;
Pisters, Louis L. ;
Kuban, Deborah A. ;
Kaplan, Irving D. ;
Wood, David P. ;
Ciezki, Jay ;
Dunn, Rodney L. ;
Carroll, Peter R. ;
Sanda, Martin G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (11) :1205-1214
[2]   Genetic markers for prediction of normal tissue toxicity after radiotherapy [J].
Alsner, Jan ;
Andreassen, Christian Nicolaj ;
Overgaard, Jens .
SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (02) :126-135
[3]   Genetic variants and normal tissue toxicity after radiotherapy: A systematic review [J].
Andreassen, Christian Nicolaj ;
Alsner, Jan .
RADIOTHERAPY AND ONCOLOGY, 2009, 92 (03) :299-309
[4]  
[Anonymous], 1995, Radiother Oncol, V35, P17
[5]  
[Anonymous], 1995, INT J RAD ONCOLOGY B, V31, P1049, DOI DOI 10.1016/0360-3016(95)90159-0
[6]   DATA BRIEFING Patient reported outcome measures: how are we feeling today? [J].
Appleby, John .
BRITISH MEDICAL JOURNAL, 2012, 344
[7]   Single Nucleotide Polymorphisms, Apoptosis, and the Development of Severe Late Adverse Effects After Radiotherapy [J].
Azria, David ;
Ozsahin, Mahmut ;
Kramar, Andrew ;
Peters, Sheila ;
Atencio, David P. ;
Crompton, Nigel E. A. ;
Mornex, Frangoise ;
Pelegrin, Andre ;
Dubois, Jean-Bernard ;
Mirimanoff, Rene-Olivier ;
Rosenstein, Barry S. .
CLINICAL CANCER RESEARCH, 2008, 14 (19) :6284-6288
[8]   Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity [J].
Barnett, Gillian C. ;
Elliott, Rebecca M. ;
Alsner, Jan ;
Andreassen, Christian N. ;
Abdelhay, Osama ;
Burnet, Neil G. ;
Chang-Claude, Jenny ;
Coles, Charlotte. E. ;
Gutierrez-Enriquez, Sara ;
Fuentes-Raspall, Maria J. ;
Alonso-Munoz, Maria C. ;
Kerns, Sarah ;
Raabe, Annette ;
Symonds, R. Paul ;
Seibold, Petra ;
Talbot, Chris J. ;
Wenz, Frederik ;
Wilkinson, Jennifer ;
Yarnold, John ;
Dunning, Alison M. ;
Rosenstein, Barry S. ;
West, Catharine M. L. ;
Bentzen, Soren M. .
RADIOTHERAPY AND ONCOLOGY, 2012, 105 (03) :289-295
[9]   Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study [J].
Barnett, Gillian C. ;
Coles, Charlotte E. ;
Elliott, Rebecca M. ;
Baynes, Caroline ;
Luccarini, Craig ;
Conroy, Don ;
Wilkinson, Jennifer S. ;
Tyrer, Jonathan ;
Misra, Vivek ;
Platte, Radka ;
Gulliford, Sarah L. ;
Sydes, Matthew R. ;
Hall, Emma ;
Bentzen, Soren M. ;
Dearnaley, David P. ;
Burnet, Neil G. ;
Pharoah, Paul D. P. ;
Dunning, Alison M. ;
West, Catharine M. L. .
LANCET ONCOLOGY, 2012, 13 (01) :65-77
[10]   RANDOMIZED CONTROLLED TRIAL OF FORWARD-PLANNED INTENSITY MODULATED RADIOTHERAPY FOR EARLY BREAST CANCER: INTERIM RESULTS AT 2 YEARS [J].
Barnett, Gillian C. ;
Wilkinson, Jennifer S. ;
Moody, Anne M. ;
Wilson, Charles B. ;
Twyman, Nicola ;
Wishart, Gordon C. ;
Burnet, Neil G. ;
Coles, Charlotte E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (02) :715-723